Evaluating the timing of triple therapy initiation for the treatment of asthma in Japan: prompt versus delayed-Reference-Cited by-同舟云学术

Evaluating the timing of triple therapy initiation for the treatment of asthma in Japan: prompt versus delayed

Published:2024-08-30 Issue: Volume: Page:1-10
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Requena Gema¹,Wood Robert²,Ito Risako³,Wild Rosie²,Mita Chifuku³,Payne Poppy²,Mukai Isao⁴,Castillo Catherine M.²,Gelwicks Steven⁵,Siddiqui Rad²,Noorduyn Stephen G.⁶⁷,Oga Toru⁸

Affiliation:

1. Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK

2. Real-world Evidence, Adelphi Real World, Bollington, Cheshire, UK

3. Value Evidence and Outcomes, GSK, Minato-ku, Tokyo, Japan

4. Medical Affairs Asthma & COPD, GSK, Minato-ku, Tokyo, Japan

5. Value Evidence and Outcomes, GSK, Collegeville, PA, USA

6. Value Evidence and Outcomes, GSK, Mississauga, ON, Canada

7. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

8. Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2024.2394152

Reference25 articles.

1. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

2. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK

3. Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma

4. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma

5. Executive summary: Japanese guidelines for adult asthma (JGL) 2021